57 related articles for article (PubMed ID: 15893099)
1. Factors predicting 2-year retention in methadone maintenance treatment for opioid dependence.
Strike CJ; Gnam W; Urbanoski K; Fischer B; Marsh DC; Millson M
Addict Behav; 2005 Jun; 30(5):1025-8. PubMed ID: 15893099
[TBL] [Abstract][Full Text] [Related]
2. Redefining retention: recovery from the patient's perspective.
Mitchell SG; Morioka R; Reisinger HS; Peterson JA; Kelly SM; Agar MH; Brown BS; O'Grady KE; Schwartz RP
J Psychoactive Drugs; 2011; 43(2):99-107. PubMed ID: 21858956
[TBL] [Abstract][Full Text] [Related]
3. A review of factors associated with methadone maintenance treatment adherence and retention in Vietnam.
Nong T; Hodgkin D; Trang NT; Shoptaw SJ; Li MJ; Hai Van HT; Le G
Drug Alcohol Depend; 2023 Feb; 243():109699. PubMed ID: 36603363
[TBL] [Abstract][Full Text] [Related]
4. The determinants of methadone maintenance treatment in opioids dependence users: A survival analysis study.
Ahmadi MA; Moradi G; Khoshravesh S; Roshani D; Qaderi N; Amjadian M
Med J Islam Repub Iran; 2020; 34():149. PubMed ID: 33437745
[No Abstract] [Full Text] [Related]
5. Retention of patients in opioid substitution treatment: A systematic review.
O'Connor AM; Cousins G; Durand L; Barry J; Boland F
PLoS One; 2020; 15(5):e0232086. PubMed ID: 32407321
[TBL] [Abstract][Full Text] [Related]
6. Mixed methods to explore factors associated with the decline of patients in the methadone maintenance treatment program in Shanghai, China.
Zhang L; Bao J; Harrington A; Fan X; Ning Z; Zhang J; Shi D; Hu M; Zhou Z; Cai Z; Zhao M; Du J
Harm Reduct J; 2019 May; 16(1):34. PubMed ID: 31133016
[TBL] [Abstract][Full Text] [Related]
7. Associated Factors of Maintenance in Patients under Treatment with Methadone: A Comprehensive Systematic Review and Meta-Analysis.
Farmani F; Farhadi H; Mohammadi Y
Addict Health; 2018 Jan; 10(1):41-51. PubMed ID: 30627384
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of Medicaid recipients in Methadone Maintenance Treatment: A comparison across the lifespan.
Cotton BP; Bryson WC; Lohman MC; Brooks JM; Bruce ML
J Subst Abuse Treat; 2018 Sep; 92():40-45. PubMed ID: 30032943
[TBL] [Abstract][Full Text] [Related]
9. Retention in medication-assisted treatment programs in Ukraine-Identifying factors contributing to a continuing HIV epidemic.
Dumchev K; Dvoryak S; Chernova O; Morozova O; Altice FL
Int J Drug Policy; 2017 Oct; 48():44-53. PubMed ID: 28800420
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of 6 remote First Nations community-based buprenorphine programs in northwestern Ontario: Retrospective study.
Mamakwa S; Kahan M; Kanate D; Kirlew M; Folk D; Cirone S; Rea S; Parsons P; Edwards C; Gordon J; Main F; Kelly L
Can Fam Physician; 2017 Feb; 63(2):137-145. PubMed ID: 28209683
[TBL] [Abstract][Full Text] [Related]
11. Club drugs and alcohol abuse predicted dropout and poor adherence among methadone maintenance treatment patients in Guangzhou, China.
Liu D; Gu J; Xu H; Hao C; Jiao M; Zhang X; Zhao Y; Andrew B; Hao Y
AIDS Care; 2017 Apr; 29(4):458-463. PubMed ID: 27903083
[TBL] [Abstract][Full Text] [Related]
12. Predictors of One-Year Retention in Methadone Maintenance Treatment (MMT) in Iran, Rafsanjan.
Sheikh Fathollahi M; Torkashvand F; Najmeddin H; Rezaeian M
Int J High Risk Behav Addict; 2016 Sep; 5(3):e29121. PubMed ID: 27803890
[TBL] [Abstract][Full Text] [Related]
13. The Future of Opioid Agonist Therapies in Ukraine: A Qualitative Assessment of Multilevel Barriers and Ways Forward to Promote Retention in Treatment.
Bojko MJ; Mazhnaya A; Marcus R; Makarenko I; Islam Z; Filippovych S; Dvoriak S; Altice FL
J Subst Abuse Treat; 2016 Jul; 66():37-47. PubMed ID: 27211995
[TBL] [Abstract][Full Text] [Related]
14. Patient perspectives of methadone formulation change in British Columbia, Canada: outcomes of a provincial survey.
Greer AM; Hu S; Amlani A; Moreheart S; Sampson O; Buxton JA
Subst Abuse Treat Prev Policy; 2016 Jan; 11():3. PubMed ID: 26762162
[TBL] [Abstract][Full Text] [Related]
15. Evaluating the Effectiveness of First-Time Methadone Maintenance Therapy Across Northern, Rural, and Urban Regions of Ontario, Canada.
Eibl JK; Gomes T; Martins D; Camacho X; Juurlink DN; Mamdani MM; Dhalla IA; Marsh DC
J Addict Med; 2015; 9(6):440-6. PubMed ID: 26484843
[TBL] [Abstract][Full Text] [Related]
16. Retention and HIV seroconversion among drug users on methadone maintenance treatment in Yunnan, China.
Chang YP; Duo L; Kumar AM; Achanta S; Xue HM; Satyanarayana S; Ananthakrishnan R; Srivastava S; Qi W; Hu SY
Public Health Action; 2014 Mar; 4(1):28-34. PubMed ID: 26423758
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of a low-threshold/high-tolerance methadone maintenance treatment clinic in saint john, new brunswick, Canada: one year retention rate and illicit drug use.
Christie TK; Murugesan A; Manzer D; O'Shaughnessey MV; Webster D
J Addict; 2013; 2013():753409. PubMed ID: 24860685
[TBL] [Abstract][Full Text] [Related]
18. Methadone treatments in a Swiss region, 2001-2008: a registry-based analysis.
Huissoud T; Rousson V; Dubois-Arber F
BMC Psychiatry; 2012 Dec; 12():238. PubMed ID: 23270305
[TBL] [Abstract][Full Text] [Related]
19. The cost of providing methadone maintenance treatment in Ontario, Canada.
Zaric GS; Brennan AW; Varenbut M; Daiter JM
Am J Drug Alcohol Abuse; 2012 Nov; 38(6):559-66. PubMed ID: 22783917
[TBL] [Abstract][Full Text] [Related]
20. Predictors of attrition from a national sample of methadone maintenance patients.
Mancino M; Curran G; Han X; Allee E; Humphreys K; Booth BM
Am J Drug Alcohol Abuse; 2010 May; 36(3):155-60. PubMed ID: 20465373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
